Longitudinal analysis of SARS-CoV-2 spike and RNA-dependent RNA polymerase protein sequences reveals the emergence and geographic distribution of diverse mutations

Berman, 2000, The Protein Data Bank, Nucleic Acids Res., 28, 235, 10.1093/nar/28.1.235

Cheng, 2020, Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation, Proc. Natl. Acad. Sci., 117, 25254, 10.1073/pnas.2010722117

Chi, 2020, A neutralizing human antibody binds to the N-terminal domain of the spike protein of SARS-CoV-2, Science., 369, 650, 10.1126/science.abc6952

Choi, 2020, Persistence and evolution of SARS-CoV-2 in an immunocompromised host, N. Engl. J. Med., 383, 2291, 10.1056/NEJMc2031364

Cock, 2009, Biopython: freely available Python tools for computational molecular biology and bioinformatics, Bioinformatics., 25, 1422, 10.1093/bioinformatics/btp163

Coutinho, 2021, Model-based estimation of transmissibility and reinfection of SARS-CoV-2 P.1 variant, Infect. Dis.

Davies, 2021, Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England, Science., 372, 10.1126/science.abg3055

den Dunnen, 2016, HGVS recommendations for the description of sequence variants: 2016 update, Hum. Mutat., 37, 564, 10.1002/humu.22981

Deng, 2021, Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant, Cell., 10.1016/j.cell.2021.04.025

Deorowicz, 2016, FAMSA: fast and accurate multiple sequence alignment of huge protein families, Sci. Rep., 6, 33964, 10.1038/srep33964

Edara, 2021, Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants, N Engl J Med, 385, 664, 10.1056/NEJMc2107799

Edgar, 2010, Search and clustering orders of magnitude faster than BLAST, Bioinformatics., 26, 2460, 10.1093/bioinformatics/btq461

Fang, 2021, Updated SARS-CoV-2 single nucleotide variants and mortality association, Health Inform.

Garcia-Beltran, 2021, Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity, Cell., 10.1016/j.cell.2021.03.013

Greaney, 2021, Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition, Cell Host Microbe, 29, 44, 10.1016/j.chom.2020.11.007

Hodcroft, 2020, Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020, Epidemiology

Hodcroft, 2021, Emergence in late 2020 of multiple lineages of SARS-CoV-2 spike protein variants affecting amino acid position 677, Infect. Dis.

Hou, 2020, SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo, Science., 370, 1464, 10.1126/science.abe8499

Hunter, 2007, Matplotlib: a 2D graphics environment, Comput. Sci. Eng., 9, 90, 10.1109/MCSE.2007.55

Jacob, 2020, Evolutionary tracking of SARS-CoV-2 genetic variants highlights intricate balance of stabilizing and destabilizing mutations, Genomics

Kim, 2020, The architecture of SARS-CoV-2 transcriptome, Cell., 181, 914, 10.1016/j.cell.2020.04.011

Korber, 2020, Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus, Cell., 182, 812, 10.1016/j.cell.2020.06.043

Liu, 2021, The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus, J. Travel Med., 28, 10.1093/jtm/taab124

Liu, 2020, The reproductive number of COVID-19 is higher compared to SARS coronavirus, J. Travel Med., 27, 10.1093/jtm/taaa021

Liu, 2021, Neutralizing activity of BNT162b2-elicited serum, N. Engl. J. Med., 3

Liu, 2021, The basis of a more contagious 501Y.V1 variant of SARS-COV-2, Biochemistry

Madhi, 2021, Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B.1.351 variant, N. Engl. J. Med., 10.1056/NEJMoa2102214

Mascola, 2021, SARS-CoV-2 viral variants—tackling a moving target, JAMA., 10.1001/jama.2021.2088

McCallum, 2021, N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2, Immunology

Millet, 2014, Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein, Proc. Natl. Acad. Sci., 111, 15214, 10.1073/pnas.1407087111

Nagy, 2021, Different mutations in SARS-CoV-2 associate with severe and mild outcome, Int. J. Antimicrob. Agents, 57, 10.1016/j.ijantimicag.2020.106272

Plotkin, 2003, Codon bias and frequency-dependent selection on the hemagglutinin epitopes of influenza a virus, Proc. Natl. Acad. Sci., 100, 7152, 10.1073/pnas.1132114100

Premkumar, 2020, The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients, Sci. Immunol., 5, 10.1126/sciimmunol.abc8413

Rogers, 2020, Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model, Science., 369, 956, 10.1126/science.abc7520

Sada, 2020, Detailed molecular interactions of Favipiravir with SARS-CoV-2, SARS-CoV, MERS-CoV, and influenza virus polymerases in silico, Microorganisms., 8, 1610, 10.3390/microorganisms8101610

Saline, 2010, The structure of superantigen complexed with TCR and MHC reveals novel insights into superantigenic T cell activation, Nat. Commun., 1, 10.1038/ncomms1117

Shu, 2017, GISAID: global initiative on sharing all influenza data – from vision to reality, Eurosurveillance., 22, 30494, 10.2807/1560-7917.ES.2017.22.13.30494

Soskine, 2010, Mutational effects and the evolution of new protein functions, Nat. Rev. Genet., 11, 572, 10.1038/nrg2808

Starr, 2020, Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding, Cell., 182, 1295, 10.1016/j.cell.2020.08.012

Steinhauer, 1999, Role of hemagglutinin cleavage for the pathogenicity of influenza virus, Virology., 258, 1, 10.1006/viro.1999.9716

Tegally, 2020, Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa, Epidemiology

Thomson, 2021, Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity, Cell., 10.1016/j.cell.2021.01.037

Volz, 2021, Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: insights from linking epidemiological and genetic data, medRxiv

Walls, 2020, Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein, Cell., 181, 281, 10.1016/j.cell.2020.02.058

Wang, 2020, Structural and functional basis of SARS-CoV-2 entry by using human ACE2, Cell., 181, 894, 10.1016/j.cell.2020.03.045

Wrobel, 2020, SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects, Nat. Struct. Mol. Biol., 27, 763, 10.1038/s41594-020-0468-7

Wu, 2020, Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China, Cell Host Microbe, 27, 325, 10.1016/j.chom.2020.02.001

Wu, 2021, mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants, bioRxiv

Yan, 2020, Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2, Science., 367, 1444, 10.1126/science.abb2762

Yin, 2020, Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir, Science., 368, 1499, 10.1126/science.abc1560

Yurkovetskiy, 2020, Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant, Cell., 183, 739, 10.1016/j.cell.2020.09.032

Zhang, 2021, Emergence of a novel SARS-CoV-2 variant in Southern California, JAMA., 10.1001/jama.2021.1612

Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature., 579, 270, 10.1038/s41586-020-2012-7

Zhou, 2021, Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera, Cell.